RPRX•benzinga•January 10, 2025 at 12:20 PM

Royalty Pharma Says It Has Agreed To Acquire Its External Manager, Rp Management, Which Will Generate Cash Savings Of Greater Than $100M In 2026 And Greater Than $175M In 2030; Company Has Approved A New $3B Share Repurchase Program

No summary available.

Read the full article from the original source for complete details and context.

Article published on January 10, 2025 by benzinga